Chapter 24: Development in Health & Disease

Abnormal development arises from three major pathways: genetic mechanisms, such as mutations or changes in chromosome number (aneuploidies, like Trisomy 21 causing Down syndrome); environmental mechanisms, involving teratogens and endocrine disruptors; and stochastic (random) events, where chance fluctuations in gene expression (transcription and translation) lead to varied phenotypes, even among genetically identical individuals. Genetic disorders are often linked in syndromes exhibiting pleiotropy, where a single gene affects multiple tissues, either independently (mosaic pleiotropy) or sequentially (relational pleiotropy). Conversely, genetic heterogeneity occurs when different gene mutations produce the same phenotype, while phenotypic heterogeneity describes how the same mutation can manifest differently across individuals. Environmental agents, termed teratogens, typically cause major congenital anomalies during the embryonic period (weeks 3 through 8). Notable teratogens include alcohol, which causes Fetal Alcohol Spectrum Disorder (FASD) by interfering with cell migration and proliferation and downregulating Sonic hedgehog (Shh) signaling, and high doses of retinoic acid, which arrests cranial neural crest cell migration, causing defects in the face and ears. A specialized class of environmental toxins, endocrine disruptors (EDs), interfere with hormone signaling by mimicking natural hormones (like DES mimicking estrogen), acting as antagonists, or altering hormone synthesis and transport. ED effects are often subtle, physiological, and may manifest later in adult life. Examples include diethylstilbestrol (DES), linked to reproductive tract abnormalities by suppressing Hoxa10 gene expression, bisphenol A (BPA) from plastics, associated with reproductive defects and increased susceptibility to breast cancer, and atrazine, a herbicide that feminizes male vertebrates by inducing aromatase, converting testosterone to estrogen. Critically, certain EDs, such as vinclozolin, can induce transgenerational inheritance by changing DNA methylation patterns (epialleles) that are transmitted through the germ line for multiple subsequent generations, even without direct exposure. Finally, the chapter views cancer as a disease of development, characterized by aberrations in differentiation and tissue organization, often resulting from defects in cell-cell communication, the misregulation of paracrine pathways (like Shh signaling), and the activity of specialized cancer stem cells (CSCs) that maintain the tumor mass. This developmental perspective informs differentiation therapy, which uses factors like retinoic acid or microRNAs to force malignant cells to differentiate back into normal, non-proliferating cell types.